Precision Therapeutics Receives Patent
October 13, 2005
Precision Therapeutics received a patent for "Method for culturing and assaying cells, No. 6,933,129." The invention relates to screening and testing of active agents, including chemotherapeutic agents, to predict potential efficacy in individual patients in whom treatment with such agents is indicated. The invention also relates to a method for screening for expression of cellular markers, secreted factors or tumor antigens by cells for determining the disease state of the cells and for monitoring the potential efficacy of treatment agents.
« Carnegie Learning Partners with LAUSD | | Imago Delivers Leap® 3000 to Tohoku University »
